290 related articles for article (PubMed ID: 24919568)
1. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Kawaguchi M; Takahashi N; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2014 Aug; 20(16):4339-48. PubMed ID: 24919568
[TBL] [Abstract][Full Text] [Related]
2. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
[TBL] [Abstract][Full Text] [Related]
3. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Miyagaki T; Suga H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Br J Dermatol; 2012 Aug; 167(2):359-67. PubMed ID: 22512719
[TBL] [Abstract][Full Text] [Related]
4. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
5. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
6. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
7. Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.
Santoro D; Marsella R; Ahrens K; Graves TK; Bunick D
Vet Dermatol; 2013 Jun; 24(3):329-36, e73. PubMed ID: 23668858
[TBL] [Abstract][Full Text] [Related]
8. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
9. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.
Clausen ML; Jungersted JM; Andersen PS; Slotved HC; Krogfelt KA; Agner T
Br J Dermatol; 2013 Sep; 169(3):587-93. PubMed ID: 23647067
[TBL] [Abstract][Full Text] [Related]
10. Expression Profiles of Genes Encoding Cornified Envelope Proteins in Atopic Dermatitis and Cutaneous T-Cell Lymphomas.
Trzeciak M; Olszewska B; Sakowicz-Burkiewicz M; Sokołowska-Wojdyło M; Jankau J; Nowicki RJ; Pawełczyk T
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32213830
[TBL] [Abstract][Full Text] [Related]
11. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
[TBL] [Abstract][Full Text] [Related]
13. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
15. Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Akamata K; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2012 Jul; 304(5):401-6. PubMed ID: 22526325
[TBL] [Abstract][Full Text] [Related]
16. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression.
Otsuka A; Doi H; Egawa G; Maekawa A; Fujita T; Nakamizo S; Nakashima C; Nakajima S; Watanabe T; Miyachi Y; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2014 Jan; 133(1):139-46.e1-10. PubMed ID: 24055295
[TBL] [Abstract][Full Text] [Related]
17. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis.
Batista DI; Perez L; Orfali RL; Zaniboni MC; Samorano LP; Pereira NV; Sotto MN; Ishizaki AS; Oliveira LM; Sato MN; Aoki V
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1091-5. PubMed ID: 25271795
[TBL] [Abstract][Full Text] [Related]
18. Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria.
Ye YM; Kim BE; Shin YS; Park HS; Leung DYM
Ann Allergy Asthma Immunol; 2014 Jun; 112(6):533-538. PubMed ID: 24726196
[TBL] [Abstract][Full Text] [Related]
19. Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunction.
Hansmann B; Ahrens K; Wu Z; Proksch E; Meyer-Hoffert U; Schröder JM
Exp Dermatol; 2012 Apr; 21(4):271-6. PubMed ID: 22417302
[TBL] [Abstract][Full Text] [Related]
20. In vivo expression of antimicrobial peptides in atopic dermatitis.
Clausen ML; Slotved HC; Krogfelt KA; Andersen PS; Agner T
Exp Dermatol; 2016 Jan; 25(1):3-9. PubMed ID: 26269388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
